Shots:
The US FDA has approved Zycubo (copper histidinate) for the treatment of pediatric patients with Menkes disease
Approval was supported by clinical data showing improved OS with early Zycubo treatment vs an untreated external control, reflecting ~80% reduction in the risk of death & a mOS of 177.1 vs 17.6mos.
Zycubo is a bioavailable…
